Abstract:Mitoxantrone (MTO) is a potent drug used to treat breast cancer; however, efforts to expand its clinical applicability have been restricted because of its high risk for cardiotoxicity. In this study, we successfully conjugated MTO or folic acid (FA) to a synthesized D-α-tocopheryl polyethylene glycol 2000 succinate (TPGS2k), herein, shortened to MCT and FCT, respectively. The two produced conjugates could self-assemble to form MCT micelles or MCT/FCT mixed micelles (FMCT) aiming to lower systemic toxicity, enhance entrapment efficiency, and provide a platform for targeted delivery. Moreover, these micellar materials showed a significantly low CMC and could be used to load MTO. The diameters of MTO-loaded micelles (MTO-MCT and MTO-FMCT) were less than 100 nm with a negative zeta potential. We further characterized the pH-responsive drug release of MTO-MCT and MTO-FMCT and then assessed their cellular uptake and antitumor efficacy in human breast cancer cell lines (MCF-7) via confocal microscopy, flow cytometry, and cytotoxicity studies. All the results revealed that both MTO-MCT and MTO-FMCT increased drug loading and entrapment efficiency and possessed sufficient pH-sensitive release. Additionally, MTO-FMCT displayed an improved uptake through folate-mediated endocytosis, resulting in a higher cytotoxic effect on MCF-7 cells compared with that of MTO-MCT. Meanwhile, both MTO-MCT and MTO-FMCT exhibited a low toxicity on hCMEC/D3 normal cells. More importantly, pharmacokinetic study demonstrated that, in comparison with free MTO injection, MTO-MCT and MTO-FMCT, respectively, achieved half-lives 11.5 and 13 times longer and a 9.7- and 5.8-fold increase in AUC. In vivo, both MTO-MCT and MTO-FMCT formulations significantly prolonged the survival time of MCF-7 tumor-bearing mice and had a better efficacy/toxicity ratio. Promisingly, MTO-FMCT micelles remarkably increased MTO accumulation in tumors in vivo, induced higher tumor cell apoptosis, and showed lower toxicity toward major organs. These results imply that MTO-FMCT may be used as a potential drug delivery system for breast cancer targeted therapy.

Study on preparation and release of mitoxantrone transfersomes in vitro

[Structure Charateristics of Mitoxantrone Transforsomes].

Preparation of mitoxantrone liposomes and study on its in vivo distribution in rats after transdermal delivery]

Enhanced Percutaneous Delivery of Methotrexate Using Micelles Prepared with Novel Cationic Amphipathic Material

Studies on preparation of long circulating mitoxantrone liposomes with transmembrane ammonium sulfate gradients

PREPARATION OF LONG CIRCULATING MITOXANTRONE LIPOSOMES AND ITS PHARMACOKINETICS

STUDY ON THE DRUG RELEASE IN VITRO OF MITOXANTRONE STARCH MICROSPHERE

Preparation and Characterization of Transfersomes of Three Drugs in Vitro

Release Profile of Compound Liposomes Entrapped with Vincristine Sulfate and Mitoxantrone Chlorhydric Acid in Vitro and Their Distribution in Mice

STUDY ON THE PREPARATION TECHNIQUES OF MITOXANTRONE LIPOSOMES

Studies on preparation of folate-conjugated mitoxantrone-loaded albumin nanoparticles and its property in vitro

Study on mitoxantrone albumin microspheres for liver targeting

Tissue Distribution and Pharmacodynamics of Chitosan-Coated Mitoxantrone Liposomes in the Tumor-Bearing Mice

RELEASE OF MITOXANTRONE FROM MITOXANTRONE ALBUMIN MICROSPHERES AND GALACTOSYL-MITOXANTRONEALBUMIN MICROSPHERES IN VITRO

Amphiphilic dextran derivatives nanoparticles for the delivery of mitoxantrone

Self-aggregated Nanoparticles of Cholesterol-modified Pullulan Conjugate as a Novel Carrier of Mitoxantronep

Slow Release Kinetics of Mitoxantrone from Ordered Mesoporous Carbon Films

Mitoxantrone- and Folate-TPGS2k Conjugate Hybrid Micellar Aggregates to Circumvent Toxicity and Enhance Efficiency for Breast Cancer Therapy.

[Primary Studies on Synthesis and Properties of Mitoxantrone-Insulin Conjugates].

[Study on Mitoxantrone Polycyanoacrylate Nanospheres].

Preparation and Functional Characterization of Tumor-Targeted Folic Acid-Chitosan Conjugated Nanoparticles Loaded with Mitoxantrone